Novartis India control shifts to ChrysCapital; 6 directors exit, 6 join

CFO resignedMultiple independent directors resignedKey managerial personnel resignedDirector resignedManagement Changes View source PDF Explain this filing

NOVARTIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹1600.00

prior close

₹1610.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-0.4% vs market

Pharmaceuticals peers, median of 162sector-0.7%-0.3% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.2

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0-0.6-0.4-0.7-0.3

Next day

-2.4+0.5-2.9-0.5-1.9

+2.8+1.9+0.9+0.2+2.6

+1.8+2.3-0.5+0.1+1.7

+2.3+3.6-1.4+0.5+1.8

-0.1+4.0-4.1+0.7-0.8

+0.2+4.0-3.7+1.4-1.2

15d

-7.3+4.9-12.2+0.4-7.7

-1.6+5.9-7.5+1.7-3.3

+19.7+4.8+14.9+2.7+17.0

+7.8pendingpending-3.1+10.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Novartis AG sold its entire 17.45 lakh equity stake in Novartis India to ChrysCapital group entities (WaveRise, Fund X, Two Infinity Partners), completing change of control on July 29, 2026. Novartis AG reclassified from promoter to public category. Open Offer also concluded. Six directors resigned, including Chairperson Christopher Snook, CFO Shilpa Joshi, Whole-time Director Falin Majmudar, and three independent directors. Six new directors appointed, three ChrysCapital nominees and three independents.

Likely market impact

Major ownership change. New promoters ChrysCapital likely to shape future strategy. Board fully reconstituted under new management. Watch for fresh business direction.